These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 20155316
1. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Di X, Gennings C, Bear HD, Graham LJ, Sheth CM, White KL, Gewirtz DA. Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316 [Abstract] [Full Text] [Related]
4. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ, Lamszus K, Goldberg ID, Rosen EM. Oncogene; 1998 Apr 30; 16(17):2229-41. PubMed ID: 9619832 [Abstract] [Full Text] [Related]
5. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373 [Abstract] [Full Text] [Related]
10. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K. Clin Cancer Res; 2005 Feb 01; 11(3):1287-93. PubMed ID: 15709200 [Abstract] [Full Text] [Related]
11. Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors. Singh P, Godbole M, Rao G, Annarao S, Mitra K, Roy R, Ingle A, Agarwal G, Tiwari S. Biochem Biophys Res Commun; 2011 Nov 11; 415(1):181-6. PubMed ID: 22027149 [Abstract] [Full Text] [Related]
12. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y. Phytother Res; 2008 Aug 11; 22(8):1125-32. PubMed ID: 18570244 [Abstract] [Full Text] [Related]
13. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Vadgama JV, Wu Y, Shen D, Hsia S, Block J. Anticancer Res; 2000 Aug 11; 20(3A):1391-414. PubMed ID: 10928049 [Abstract] [Full Text] [Related]
14. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Tyagi AK, Agarwal C, Chan DC, Agarwal R. Oncol Rep; 2004 Feb 11; 11(2):493-9. PubMed ID: 14719089 [Abstract] [Full Text] [Related]
19. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F, Duivenvoorden WC, Singh G. Anticancer Drugs; 2009 Feb 11; 20(2):115-22. PubMed ID: 19209028 [Abstract] [Full Text] [Related]
20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O, Arce F, Gätjens-Boniche O, Díaz C. Biomed Pharmacother; 2007 Jul 11; 61(6):347-55. PubMed ID: 17399942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]